# Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer

> **NCT00077103** · PHASE1,PHASE2 · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 4 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** pegfilgrastim
- **DRUG:** cisplatin
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** fosbretabulin disodium
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00077103
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-11
- **Primary completion:** 2007-02
- **Final completion:** 2007-12
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077103, "Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00077103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*